HHS USA.gov. Graiouid EM, Chakir Y, Gallouo M, Dakir M, Debbagh A, Aboutaieb R. Pan Afr Med J. Get the latest public health information from CDC: https://www.coronavirus.gov, Get the latest research information from NIH: https://www.nih.gov/coronavirus, Find NCBI SARS-CoV-2 literature, sequence, and clinical content: https://www.ncbi.nlm.nih.gov/sars-cov-2/. Further treatment is directed according to disease stage, histology, and age of the patient. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Embryonal rhabdomyosarcoma is a common tumor of children, rarely appearing in the scrotum from tunica vaginalis or paratesticular tissues. Surgical Pathology Criteria Diagnostic Criteria General Embryonal Rhabdomyosarcoma Alveolar Rhabdomyosarcoma Mixed Alveolar - Embryonal Sclerosing Rhabdomyosarcoma Pleomorphic Rhabdomyosarcoma … Boudahna L, Benbrahim Z, Amaadour L, Mazouz A, Benhayoune K, Tahiri Y, Farih MH, Amarti A, Arifi S, Mellas N. Pan Afr Med J. A rare case of paratesticular embryonal rhabdomyosarcoma diagnosed by fine needle aspiration: a case report. Pathology The masses can be … 2018 Jun;97(25):e11164. NLM The Intergroup Rhabdomyosarcoma Study-I: A Final Report MAURER H, BELTANGADY M, GEHAN E, et al. Paratesticular rhabdomyosarcoma: Importance of initial therapy. Paratesticular rhabdomyosarcoma (PT-RMS) accounts for 7% to 10% of all genitourinary tract RMS tumors and is the third most common following that of the prostate and bladder. Keywords: In both cases a retroperitoneal disease was present … Though most (60%-80%) … Inappropriate first surgery (InFS) required supplementary treatment to maintain excellent … Inappropriate first surgery (InFS) required supplementary treatment to maintain excellent outcomes. Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group. Epub 2013 Jan 24. The management of … Paratesticular rhabdomyosarcoma accounts for 7-10% of genitourinary rhabdomyosarcoma tumors and is the 3rd most common after RMS of the prostate and bladder. Staging paratesticular rhabdomyosarcoma in the "as low as reasonably achievable" age: the case for PET-CT. [Paratesticular rhabdomyosarcoma: a case report]. Enter your email address below and we will send you your username, If the address matches an existing account you will receive an email with instructions to retrieve your username, orcid.org/https://orcid.org/0000-0002-3799-1245, orcid.org/https://orcid.org/0000-0001-7451-8476, orcid.org/https://orcid.org/0000-0003-4462-5523, I have read and accept the Wiley Online Library Terms and Conditions of Use, Supporting Information TABLE S1 Risk stratification and treatment for EpSSG nonmetastatic PT RMS (RMS 2005 study), Supporting Information TABLE S2 Distribution of patients by risk subgroup after retrospective central pathology review. The risk of progression could be reduced with appropriate … Of 26 recurrences, the risk of relapse was higher in patients ≥10 years (21/26) and was mainly locoregional in 16 of 26 recurrences (± metastatic). Ferrari A, Casanova M, Massimino M, et al. Analysis was performed on 237 patients, with median follow up of 67.1 months. Age … This site needs JavaScript to work properly. Treatment is based on multimodal therapy as well as on surgery, chemotherapy and radiotherapy. 2019 May 24;33:55. doi: 10.11604/pamj.2019.33.55.17269. PARATESTICULAR MYXOMA: CASE REPORT AND REVIEW STEPHEN F. SCHIFF,* MARY F. LACHMAN AND LYNWOOD HAMMERS From the Departments of Surgery, Section of Urology, Pathology …